Altrius Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Sell
1,173
-46
-4% -$47K 0.27% 70
2026
Q1
$1.12M Buy
1,219
+3
+0.2% +$3.04K 0.22% 71
2025
Q4
$1.31M Sell
1,216
-5
-0.4% -$4.78K 0.28% 69
2025
Q3
$932K Hold
1,221
– – 0.21% 71
2025
Q2
$952K Sell
1,221
-17
-1% -$13.2K 0.22% 71
2025
Q1
$1.02M Sell
1,238
-26
-2% -$21.6K 0.25% 69
2024
Q4
$976K Sell
1,264
-21
-2% -$17.4K 0.26% 69
2024
Q3
$1.14M Buy
1,285
+13
+1% +$11.7K 0.29% 66
2024
Q2
$1.15M Buy
1,272
+85
+7% +$68K 0.3% 67
2024
Q1
$923K Buy
1,187
+10
+0.8% +$7.12K 0.23% 71
2023
Q4
$686K Buy
1,177
+7
+0.6% +$4.09K 0.19% 76
2023
Q3
$628K Sell
1,170
-93
-7% -$47.9K 0.19% 77
2023
Q2
$592K Sell
1,263
-63
-5% -$26.4K 0.18% 77
2023
Q1
$455K Hold
1,326
– – 0.14% 78
2022
Q4
$485K Hold
1,326
– – 0.15% 82
2022
Q3
$428K Buy
1,326
+126
+11% +$39.9K 0.16% 80
2022
Q2
$389K Buy
+1,200
New +$360K 0.13% 81

Other funds holding LLY

Altrius Capital Management's LLY Position: Q2 2026 in Review

Altrius Capital Management reduced its Eli Lilly (LLY) stake by 3.8% in Q2 2026, selling an estimated $47K and leaving 1,173 shares worth $1.41M. The position accounts for 0.27% of the portfolio, ranked #70.

Altrius Capital Management first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Altrius Capital Management held 1,173 shares of Eli Lilly worth $1.41M as of Q2 2026.
  • Altrius Capital Management sold 46 Eli Lilly shares in Q2 2026, an estimated $47K.
  • Eli Lilly made up 0.27% of Altrius Capital Management's portfolio in Q2 2026, its #70 holding.
  • Altrius Capital Management first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Altrius Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.